Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer

Jae Yong Park, Hyo Sung Jeon, Sun Ha Park, Tae In Park, Ji Woong Son, Chang Ho Kim, Jae Ho Park, In-San Kim, Tae Hoon Jung, Su Han Jun

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Microsatellite alteration (MSA) has been observed in a fraction of non-small cell lung cancer (NSCLC). Most prior studies regarding MSA in lung cancer have usually used adjacent non-malignant lung tissues as a source of constitutional DNA. However, these normal tissues might have genetic alterations because the entire field of bronchial tree is exposed to the same carcinogenic insult. The aim of this study was to search if MSA is present in the histologically normal lung tissue of patients with NSCLC. Tumor and corresponding normal lung tissue specimens were obtained from 20 patients with NSCLC. Normal lung tissue specimens were obtained from either the opposite end of resected surgical samples or as distant from the tumor as possible. They were examined histopathologically and confirmed as normal by H-E stain. Patients' peripheral lymphocytes were used as the source for the normal DNA. Sixteen markers on 3p and 9p (nine and seven markers, respectively) were used. MSA was detected in seven of 20 (35%) histologically normal lung tissue specimens at a frequency similar to that observed in tumor tissue (eight of 20, 40%). Five cases showed MSA in both normal lung tissue and the corresponding tumor. In these five cases, MSA in normal lung tissue was detected at the same microsatellite markers which MSA was detected in the corresponding tumor. The number and size of novel bands in normal lung tissue was identical to that in tumor tissue except in one case. In which case, the same pattern of MSA was found in both normal lung tissue and corresponding tumor tissue at two markers. However, at one marker, while one identical novel band was detected in normal lung tissue and corresponding tumor tissue, another novel band was found only in tumor tissue. In two of 12 patients whose tumor was negative for the presence of MSA, MSA was detected in normal lung tissue. These results indicate that genetic alterations are widely distributed in the lung tissue of patients with lung cancer and provide considerable support for the field cancerization theory. Screening for MSA in resected normal lung tissue might be a new method to identify patients at high risk for developing second primary lung cancers. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)83-89
Number of pages7
JournalLung Cancer
Volume30
Issue number2
DOIs
Publication statusPublished - 2000 Nov 30
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Microsatellite Repeats
Lung
Neoplasms
Lung Neoplasms
Second Primary Neoplasms
DNA

Keywords

  • Histologically normal lung tissue
  • Lung cancer
  • Microsatellite alteration

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Park, J. Y., Jeon, H. S., Park, S. H., Park, T. I., Son, J. W., Kim, C. H., ... Jun, S. H. (2000). Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer. Lung Cancer, 30(2), 83-89. https://doi.org/10.1016/S0169-5002(00)00189-6

Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer. / Park, Jae Yong; Jeon, Hyo Sung; Park, Sun Ha; Park, Tae In; Son, Ji Woong; Kim, Chang Ho; Park, Jae Ho; Kim, In-San; Jung, Tae Hoon; Jun, Su Han.

In: Lung Cancer, Vol. 30, No. 2, 30.11.2000, p. 83-89.

Research output: Contribution to journalArticle

Park, JY, Jeon, HS, Park, SH, Park, TI, Son, JW, Kim, CH, Park, JH, Kim, I-S, Jung, TH & Jun, SH 2000, 'Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer', Lung Cancer, vol. 30, no. 2, pp. 83-89. https://doi.org/10.1016/S0169-5002(00)00189-6
Park, Jae Yong ; Jeon, Hyo Sung ; Park, Sun Ha ; Park, Tae In ; Son, Ji Woong ; Kim, Chang Ho ; Park, Jae Ho ; Kim, In-San ; Jung, Tae Hoon ; Jun, Su Han. / Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer. In: Lung Cancer. 2000 ; Vol. 30, No. 2. pp. 83-89.
@article{b585c8de89224a8b8f3a22a723e71cfb,
title = "Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer",
abstract = "Microsatellite alteration (MSA) has been observed in a fraction of non-small cell lung cancer (NSCLC). Most prior studies regarding MSA in lung cancer have usually used adjacent non-malignant lung tissues as a source of constitutional DNA. However, these normal tissues might have genetic alterations because the entire field of bronchial tree is exposed to the same carcinogenic insult. The aim of this study was to search if MSA is present in the histologically normal lung tissue of patients with NSCLC. Tumor and corresponding normal lung tissue specimens were obtained from 20 patients with NSCLC. Normal lung tissue specimens were obtained from either the opposite end of resected surgical samples or as distant from the tumor as possible. They were examined histopathologically and confirmed as normal by H-E stain. Patients' peripheral lymphocytes were used as the source for the normal DNA. Sixteen markers on 3p and 9p (nine and seven markers, respectively) were used. MSA was detected in seven of 20 (35{\%}) histologically normal lung tissue specimens at a frequency similar to that observed in tumor tissue (eight of 20, 40{\%}). Five cases showed MSA in both normal lung tissue and the corresponding tumor. In these five cases, MSA in normal lung tissue was detected at the same microsatellite markers which MSA was detected in the corresponding tumor. The number and size of novel bands in normal lung tissue was identical to that in tumor tissue except in one case. In which case, the same pattern of MSA was found in both normal lung tissue and corresponding tumor tissue at two markers. However, at one marker, while one identical novel band was detected in normal lung tissue and corresponding tumor tissue, another novel band was found only in tumor tissue. In two of 12 patients whose tumor was negative for the presence of MSA, MSA was detected in normal lung tissue. These results indicate that genetic alterations are widely distributed in the lung tissue of patients with lung cancer and provide considerable support for the field cancerization theory. Screening for MSA in resected normal lung tissue might be a new method to identify patients at high risk for developing second primary lung cancers. (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "Histologically normal lung tissue, Lung cancer, Microsatellite alteration",
author = "Park, {Jae Yong} and Jeon, {Hyo Sung} and Park, {Sun Ha} and Park, {Tae In} and Son, {Ji Woong} and Kim, {Chang Ho} and Park, {Jae Ho} and In-San Kim and Jung, {Tae Hoon} and Jun, {Su Han}",
year = "2000",
month = "11",
day = "30",
doi = "10.1016/S0169-5002(00)00189-6",
language = "English",
volume = "30",
pages = "83--89",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer

AU - Park, Jae Yong

AU - Jeon, Hyo Sung

AU - Park, Sun Ha

AU - Park, Tae In

AU - Son, Ji Woong

AU - Kim, Chang Ho

AU - Park, Jae Ho

AU - Kim, In-San

AU - Jung, Tae Hoon

AU - Jun, Su Han

PY - 2000/11/30

Y1 - 2000/11/30

N2 - Microsatellite alteration (MSA) has been observed in a fraction of non-small cell lung cancer (NSCLC). Most prior studies regarding MSA in lung cancer have usually used adjacent non-malignant lung tissues as a source of constitutional DNA. However, these normal tissues might have genetic alterations because the entire field of bronchial tree is exposed to the same carcinogenic insult. The aim of this study was to search if MSA is present in the histologically normal lung tissue of patients with NSCLC. Tumor and corresponding normal lung tissue specimens were obtained from 20 patients with NSCLC. Normal lung tissue specimens were obtained from either the opposite end of resected surgical samples or as distant from the tumor as possible. They were examined histopathologically and confirmed as normal by H-E stain. Patients' peripheral lymphocytes were used as the source for the normal DNA. Sixteen markers on 3p and 9p (nine and seven markers, respectively) were used. MSA was detected in seven of 20 (35%) histologically normal lung tissue specimens at a frequency similar to that observed in tumor tissue (eight of 20, 40%). Five cases showed MSA in both normal lung tissue and the corresponding tumor. In these five cases, MSA in normal lung tissue was detected at the same microsatellite markers which MSA was detected in the corresponding tumor. The number and size of novel bands in normal lung tissue was identical to that in tumor tissue except in one case. In which case, the same pattern of MSA was found in both normal lung tissue and corresponding tumor tissue at two markers. However, at one marker, while one identical novel band was detected in normal lung tissue and corresponding tumor tissue, another novel band was found only in tumor tissue. In two of 12 patients whose tumor was negative for the presence of MSA, MSA was detected in normal lung tissue. These results indicate that genetic alterations are widely distributed in the lung tissue of patients with lung cancer and provide considerable support for the field cancerization theory. Screening for MSA in resected normal lung tissue might be a new method to identify patients at high risk for developing second primary lung cancers. (C) 2000 Elsevier Science Ireland Ltd.

AB - Microsatellite alteration (MSA) has been observed in a fraction of non-small cell lung cancer (NSCLC). Most prior studies regarding MSA in lung cancer have usually used adjacent non-malignant lung tissues as a source of constitutional DNA. However, these normal tissues might have genetic alterations because the entire field of bronchial tree is exposed to the same carcinogenic insult. The aim of this study was to search if MSA is present in the histologically normal lung tissue of patients with NSCLC. Tumor and corresponding normal lung tissue specimens were obtained from 20 patients with NSCLC. Normal lung tissue specimens were obtained from either the opposite end of resected surgical samples or as distant from the tumor as possible. They were examined histopathologically and confirmed as normal by H-E stain. Patients' peripheral lymphocytes were used as the source for the normal DNA. Sixteen markers on 3p and 9p (nine and seven markers, respectively) were used. MSA was detected in seven of 20 (35%) histologically normal lung tissue specimens at a frequency similar to that observed in tumor tissue (eight of 20, 40%). Five cases showed MSA in both normal lung tissue and the corresponding tumor. In these five cases, MSA in normal lung tissue was detected at the same microsatellite markers which MSA was detected in the corresponding tumor. The number and size of novel bands in normal lung tissue was identical to that in tumor tissue except in one case. In which case, the same pattern of MSA was found in both normal lung tissue and corresponding tumor tissue at two markers. However, at one marker, while one identical novel band was detected in normal lung tissue and corresponding tumor tissue, another novel band was found only in tumor tissue. In two of 12 patients whose tumor was negative for the presence of MSA, MSA was detected in normal lung tissue. These results indicate that genetic alterations are widely distributed in the lung tissue of patients with lung cancer and provide considerable support for the field cancerization theory. Screening for MSA in resected normal lung tissue might be a new method to identify patients at high risk for developing second primary lung cancers. (C) 2000 Elsevier Science Ireland Ltd.

KW - Histologically normal lung tissue

KW - Lung cancer

KW - Microsatellite alteration

UR - http://www.scopus.com/inward/record.url?scp=0033727894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033727894&partnerID=8YFLogxK

U2 - 10.1016/S0169-5002(00)00189-6

DO - 10.1016/S0169-5002(00)00189-6

M3 - Article

C2 - 11086201

AN - SCOPUS:0033727894

VL - 30

SP - 83

EP - 89

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -